Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients' response to endocrine therapies

Louis P. Pertschuk, Ellis H. Tobin, Eric Gaetjens, Anne C. Carter, George A. Degenshein, Norman D. Bloom, David J. Brigati

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand‐conjugates composed of 17β‐estradiol and 11α‐hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescin isothiocyanate were employed. Results were compared with those of conventional biochemical receptor assays and correlated for ER in 92% of 314 tumors and for PgR in 86% of 86 specimens. ER and PgR determinations by both assay systems were correlated with clinical response to various endocrine therapies in 40 women with Stage IV disease. The histochemical assay enabled successful prediction of response in 80% of cases including eight which could not be fully analyzed biochemically.

Original languageEnglish
Pages (from-to)2896-2901
Number of pages6
JournalCancer
Volume46
Issue number12 S
DOIs
StatePublished - 15 Dec 1980
Externally publishedYes

Fingerprint

Dive into the research topics of 'Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients' response to endocrine therapies'. Together they form a unique fingerprint.

Cite this